januxrx.com - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi JANX

Logo grafis Janux Therapeutics Inc (JANX)

What is the status of Janux Therapeutics (JANX) profitability within the precision medicine market? The EBITDA trajectory reflects current dynamics, with the metric currently standing at 0.00. Janux Therapeutics develops T-cell activators for targeted strikes against tumors. Innovative molecules ensure the safety of healthy organs, while global humanitarian protocols completely neutralize any geopolitical risks to the business.

Bathi sadurunge mbayar bunga, pajak, lan amortisasi: Janux Therapeutics (JANX) kanggo 23.11.2025 - 14.11.2026

Janux Therapeutics, Inc. - rincian analitis lan metrik utama (JANX)

- nilai pasar lan prakiraan target analis:
Rega bursa Janux Corp|JANX - Target konsensus
- rincian nilai pasar emiten:
Nilai pasar Janux Therapeutics|JANX - Nilai Perusahaan
- informasi kapitalisasi buku:
Aset Bersih saben Saham Janux Therapeutics|JANX - Nilai Buku Perusahaan|Rasio Kapitalisasi marang Aset Bersih januxrx.com|JANX - Aset Agregat Perusahaan
- rincian struktur utang lan likuiditas bisnis:
Rasio Total Utang marang Ekuitas Janux Therapeutics|JANX - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal Janux Therapeutics Inc|JANX - Utang perusahaan|Rasio utang marang nilai buku Janux Therapeutics|JANX - Utang jangka dawa perusahaan|Utang jangka cendhak Janux Therapeutics|Likuiditas kritis januxrx.com
- indikator profitabilitas perusahaan lan kelipatan valuasi:
JANX - Penghasilan resik|Bathi resik mangsa ngarep Janux Therapeutics|JANX - Pangali P/E|Pangali mangsa ngarep rega marang bathi januxrx.com|JANX - Pangali PEG|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Janux Therapeutics|JANX - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi saben saham sajroning taun lumaku Janux Therapeutics|JANX - Bathi resik saben saham (EPS TTM)|Wutah bathi EPS kuartalan januxrx.com|JANX - Wutah bathi saben saham ing taun lumaku|Prakiraan owah-owahan bathi resik saben saham kanggo taun ngarep Janux Therapeutics
- data dodolan lan asil:
JANX - Dodolan perusahaan|Volume dodolan sing dikarepake perusahaan Janux Corp|JANX - Rasio rega marang pendapatan|Rasio rega marang pendapatan sing dikarepake Janux Therapeutics
Analisis kabeh metrik perusahaan:Janux Corp - JANX
Produk seri Janux Therapeutics, Inc.

Investors use this indicator to assess operational resilience and the business's ability to generate cash flow. The metric captures the daily volume of profit from core operations before depreciation and interest. For Janux Therapeutics (JANX), this reflects the commercialization efficiency of the TRACTIT platform within the precision oncology segment. Actual EBITDA dynamics demonstrate the pace of transition from development to market capture. Analysis based on actual EBITDA allows for the determination of the company's maturity stage.

Pesaing Janux Therapeutics (JANX)

NantKwest (IBRX) - Bathi sadurunge bunga, pajak, lan amortisasi|IMCR: Bathi operasional sadurunge ngurangi amortisasi|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi RCUS (arcusbio.com)|ZYME: Bathi operasional EBITDA|TNGX - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Iovance|Bathi operasional sadurunge ngurangi amortisasi Immatics Biotechnologies (IMTX)|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Xencor, Inc. (XNCR)|Bathi operasional sadurunge ngurangi amortisasi compasstherapeutics.com CMPX|Replimune - Bathi operasional sadurunge ngurangi amortisasi|Bathi operasional EBITDA Lyell LYEL|IPHA - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|PYXS (Pyxis Oncology, Inc.) - Bathi operasional sadurunge amortisasi|cgen.com (CGEN) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi sadurunge bunga, pajak, lan amortisasi iobiotech.com (IOBT)|Bathi operasional sadurunge ngurangi amortisasi STRO|INKT - Bathi operasional sadurunge potongan amortisasi|Bathi operasional sadurunge ngurangi amortisasi HOWL (Werewolf Therapeutics)|Bathi perusahaan sadurunge pajak, bunga, lan amortisasi IMMX|Bathi operasional EBITDA ALXO (ALX Oncology)|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi CUE|PDS Biotechnology Corp - Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi Sonnet BioTherapeutics|MAIA Biotechnology Inc (MAIA) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Liminatus - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|LVTX (LAVA Therapeutics NV) - Bathi operasional EBITDA|Bathi operasional EBITDA nextcure.com|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Leap Therapeutics, Inc. (LPTX)|INTS: Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi|Sensei Biotherapeutics, Inc. - Bathi operasional sadurunge ngurangi amortisasi|Theriva Corp (TOVX) - Bathi sadurunge bunga, pajak, lan amortisasi|GRTS - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|kinetabio.com - Bathi perusahaan sadurunge pajak, bunga, lan amortisasi|NEXI: Bathi operasional EBITDA|Turnstone Biologics Corp. (TSBX) - Bathi operasional EBITDA|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Vaccinex, Inc|Bathi operasional sadurunge amortisasi HARP (Harpoon Therapeutics Corp)